logo
logo

Route 92 Medical Raises $111 Million In Combined Series E And Debt Financing

Dec 14, 2021•almost 4 years ago

Amount Raised

$111 Million

Round Type

series e

San MateoFinancial Services

Description

Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced that it has raised over $110 million in a combined Series E and debt financing. The capital raise consisted of a $56 million Series E financing round led by new investors InnovaHealth Partners and Norwest Venture Partners. The round was also supported by existing Route 92 Medical investors The Vertical Group and U.S. Venture Partners

Company Information

Company

Route 92 Medical

Location

San Mateo, California, United States

About

The Route 92 Medical platform utilizes the Monopoint operating system including an 088 catheter delivered to the neurovasculature using the specialized Tenzing catheter. The firm focuses on a diversified portfolio of lead investment positions and collaborates closely with each management team. The firm invests in early to late-stage businesses across a wide range of sectors with a focus on consumer, enterprise, and healthcare.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech